“港澳药械通”第四批指定医疗机构公布

Core Viewpoint - The Guangdong Provincial Health Commission and the Guangdong Provincial Drug Administration have issued a notice regarding the fourth batch of designated medical institutions under the "Hong Kong-Macao Medical Device and Drug Access" initiative, adding 27 new hospitals while removing one [1] Group 1: Designated Medical Institutions - The new designated hospitals include 27 medical institutions such as the Southern Medical University Zhujiang Hospital, while the Foshan Ximalin Shunchao Eye Hospital has been removed from the list [1] - The application process for the fourth batch of designated medical institutions began in August, with a review of the qualifications of the previous three batches [1] - A total of 44 hospitals passed the qualification review, and the current total of designated medical institutions has reached 71 [1] Group 2: Regulatory and Operational Requirements - The notice mandates that relevant municipal administrative departments enhance supervision and management of designated medical institutions [1] - Designated medical institutions are required to deepen cooperation with Hong Kong and Macao in medical services, clinical research, and the importation of medical devices and drugs [1] - The initiative aims to ensure that imported Hong Kong and Macao medical devices and drugs are used solely for specific medical purposes within the institutions, ensuring safety in medication and equipment [1] Group 3: Historical Context and Impact - The "Hong Kong-Macao Medical Device and Drug Access" initiative was officially implemented in Guangdong Province in 2021, with three previous batches of designated institutions announced in August 2021, February 2023, and September 2024 [1] - A total of 140 varieties of drugs and medical devices (63 drugs and 77 devices) have been approved for import and use, benefiting approximately 17,000 patients [1]